NCT02280642View on ClinicalTrials.gov

Alternate Dosing Schedules Study for HPV Vaccine (ADS)

CompletedOBSERVATIONAL
Enrollment

331

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Cervical CancerGenital Warts
Interventions
BIOLOGICAL

Both 2nd and 3rd doses on time

BIOLOGICAL

2nd dose late and 3rd dose on time

BIOLOGICAL

2nd dose on time and 3rd dose late

BIOLOGICAL

Both doses late

Trial Locations (3)

27514

Chapel Hill Pediatrics, Chapel Hill

27704

Duke Children's Primary Care, Durham

Durham Pediatrics, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Duke University

OTHER